Blue Bell, PA, United States of America

Pingyu Zhong

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 6.4

ph-index = 8

Forward Citations = 494(Granted Patents)


Location History:

  • Mountain View, CA (US) (2004 - 2011)
  • Blue Bell, PA (US) (2008 - 2015)

Company Filing History:


Years Active: 2004-2015

Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: Innovations of Pingyu Zhong in PCSK9 Antagonists

Introduction

Pingyu Zhong is a notable inventor based in Blue Bell, PA (US), recognized for his significant contributions to the field of biochemistry and pharmacology. He holds a total of 15 patents, showcasing his innovative approach to developing therapeutic agents.

Latest Patents

Among his latest patents are the 1B20 PCSK9 antagonists and AX132 PCSK9 antagonists. These inventions focus on antagonists of human proprotein convertase subtilisin-kexin type 9 (PCSK9). The disclosed antagonists are effective in inhibiting PCSK9 function, making them valuable for treating conditions associated with PCSK9 activity. The patents also include nucleic acids encoding these antagonists, vectors, host cells, and compositions comprising the antagonists. Additionally, methods for creating PCSK9-specific antagonists and their applications for inhibiting or antagonizing PCSK9 function are detailed in these patents.

Career Highlights

Pingyu Zhong has worked with prominent companies in the pharmaceutical industry, including Abmaxis, Inc. and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field of drug discovery and development.

Collaborations

Throughout his career, Pingyu Zhong has collaborated with talented individuals such as Yan Li and Kevin Caili Wang. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.

Conclusion

Pingyu Zhong's work in developing PCSK9 antagonists represents a significant advancement in therapeutic options for conditions related to PCSK9 activity. His contributions to the field are noteworthy and continue to impact the landscape of biopharmaceutical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…